Mizuho Markets Americas’s ANI Pharmaceuticals ANIP Stock Holding History

Mizuho Markets Americas’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.4M	Sell	209,644 -1,124	-0.5%	-$90.2K	0.27%	75
2026 Q1	$16.2M	Buy	210,768 +8,774	+4%	+$685K	0.44%	59
2025 Q4	$15.9M	Buy	201,994 +21,416	+12%	+$1.85M	0.31%	80
2025 Q3	$16.5M	Sell	180,578 -32,252	-15%	-$2.63M	0.31%	61
2025 Q2	$13.9M	Buy	212,830 +15,357	+8%	+$1,000K	0.42%	46
2025 Q1	$13.2M	Sell	197,473 -3,145	-2%	-$188K	0.27%	68
2024 Q4	$11.1M	Buy	200,618 +5,005	+3%	+$287K	0.2%	82
2024 Q3	$11.7M	Buy	+195,613	New	+$11.9M	0.24%	55

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mizuho Markets Americas's ANIP Position: Q2 2026 in Review

Mizuho Markets Americas reduced its ANI Pharmaceuticals (ANIP) stake by 0.53% in Q2 2026, selling an estimated $90.2K and leaving 209,644 shares worth $17.4M. The position accounts for 0.27% of the portfolio, ranked #75.

Mizuho Markets Americas first reported a position in ANIP in Q3 2024 and has held it in 8 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

Mizuho Markets Americas held 209,644 shares of ANI Pharmaceuticals worth $17.4M as of Q2 2026.
Mizuho Markets Americas sold 1,124 ANI Pharmaceuticals shares in Q2 2026, an estimated $90.2K.
ANI Pharmaceuticals made up 0.27% of Mizuho Markets Americas's portfolio in Q2 2026, its #75 holding.
Mizuho Markets Americas first reported a position in ANI Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Mizuho Markets Americas's 13F filing for Q2 2026, filed 24 Jul 2026.